Uterine / Endometrial

To find out more about eligibility criteria, click on the ClinicalTrials.gov links and if you are interested in participating, email the coordinator by clicking on the envelope next to the coordinator's name and notify the coordinator. 


Treatment stage
Protocol Title 
ClinicalTrials.Gov Link
Penn Research Coordinator 
Am I Eligible?
Recurrent ATRN: A Phase 1/2a, Open-Label, Safety, Pharmacokinetic, and Preliminary Efficacy Study of Oral ATRN-119 in Patients with Advanced Solid Tumors NCT04905914 Andrea Standish, RN Eligibility Criteria

TPST-1495: Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

NCT04344795 Jennifer Louie Eligibility Criteria 
Recurrent NP-G2-044-P2-01: NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies NCT05023486 Shavon Rochester Eligibility Criteria
Recurrent NRG-GY031: A Phase 1B Study of Combination ATR (M1774) and BET Inhibition (ZEN003694) to Exploit ARID1A Loss in Recurrent Ovarian and Endometrial Cancer NCT05950464 Christine Pae Eligibility Criteria
Recurrent A Phase 1/2 Study of CPI-0209 in Patients with Advanced Solid Tumors and Lymphomas NCT04104776 Destany Fields Eligibility Criteria
Recurrent First-in-human, open-label, dose-escalation trial with expansion cohorts to evaluate safety of GEN1047 in subjects with malignant solid tumors NCT05180474 Katie Hayes, RN Eligibility Criteria
Primary Radiation

GynWPProton: Whole Pelvis Proton Radiation for Gynecologic Cancer

NCT05758688 Kelly Clark Eligibility Criteria